Crossmark

Synthesis, Anticancer Evaluation, and Molecular Docking Study of 1,2,3-Triazole-Containing Hydrazones as Potential HER2 Kinase Inhibitors

Published Online: 2024-05-19

Published Print: 2024-03

Authors

Das, V. B.

Poojary, B.

Kamat, V.

Hamzad, S.

Suman, P.
License Information

Text and Data Mining valid from 2024-03-01

Version of Record valid from 2024-03-01
More Information

Article History

Received: 10 July 2023

Revised: 6 August 2023

Accepted: 8 August 2023

First Online: 19 May 2024

CONFLICT OF INTEREST

: The authors declare that they have no conflicts of interest.

Document is current